With the analysis among 223 patents, we discovered top 153 key players by total patent application. Genentech, Inc., German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), The General Hospital Corp. are dominant in this area. They take 15.70% of the total patent filing.
California, United States
Patent: 14
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
The General Hospital Corp.
Massachusetts, United States
Patent: 4
Hangzhou Neoantigen Therapeutics Co., Ltd.
Zhejiang Sheng, China
Patent: 4
Shanghai Cp Guojian Pharmaceutical Co Ltd.
Shanghai Shi, China
Patent: 4
Shenzhen Kangjuzheng Pharmaceutical Technology Co., Ltd.
Guangdong Sheng, China
Patent: 4
Hangzhou Xingao Biotechnology Co., Ltd.
Zhejiang Sheng, China
Patent: 4
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Guangdong Sheng, China
Patent: 2
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Jiangsu Sheng, China
Patent: 2
Medical Diagnostic Laboratories LLC
New Jersey, United States
Patent: 2
With the analysis among 3 patents, we discovered top 2 start-ups by total patent application.
Institut National de la Santé et de la Recherche Médicale
Juventas Cell Therapy Ltd.
Tianjin Shi, China
Patent: 1
With the analysis among related 258 patents applied in the last 5 years. We discover 201 most active companies in this area. The fast-growing Yantai University, Shanghai Institute of Materia Medica Chinese Academy of Sciences, Sun Yat-Sen University take 9.30% of patent filing during this period.
Shandong Sheng, China
Patent: 9
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 8
Guangdong Sheng, China
Patent: 7
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 6
Shanghai Cp Guojian Pharmaceutical Co Ltd.
Shanghai Shi, China
Patent: 4
Zhejiang Sheng, China
Patent: 4
Hangzhou Neoantigen Therapeutics Co., Ltd.
Zhejiang Sheng, China
Patent: 4
Guangxi University of Chinese Medicine
Guangxi Zhuangzu Zizhiqu, China
Patent: 4
Henan Sheng, China
Patent: 3
Guangxi Normal University
Guangxi Zhuangzu Zizhiqu, China
Patent: 2
With the analysis among related 258 patents in last 5 years, we discover 163 new entrants. Yantai University, Hangzhou Neoantigen Therapeutics Co., Ltd., Guangxi University of Chinese Medicine are the most active new entrants in this area.
Shandong Sheng, China
Patent: 9
Hangzhou Neoantigen Therapeutics Co., Ltd.
Zhejiang Sheng, China
Patent: 4
Guangxi University of Chinese Medicine
Guangxi Zhuangzu Zizhiqu, China
Patent: 4
Shanghai Cp Guojian Pharmaceutical Co Ltd.
Shanghai Shi, China
Patent: 4
Henan Sheng, China
Patent: 3
Guangxi Normal University
Guangxi Zhuangzu Zizhiqu, China
Patent: 2
Guangdong Pharmaceutical University
Guangdong Sheng, China
Patent: 2
Institute of Zoology, Chinese Academy of Sciences
undefined undefined
Patent: 2
Chengdu University of Traditional Chinese Medicine
Sichuan Sheng, China
Patent: 2
Lithuanian University of Health Sciences
With the analysis among 329 patents, we discovered top 134 universities and scientific research institutions by total patent application. Shanghai Institute of Materia Medica Chinese Academy of Sciences, Sun Yat-Sen University, Zhejiang University are dominant in this area. They take 10.03% of the total patent filing.
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 13
Guangdong Sheng, China
Patent: 10
Zhejiang Sheng, China
Patent: 10
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 10
Shandong Sheng, China
Patent: 9
Henan Sheng, China
Patent: 6
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 5
Cold Spring Harbor Laboratory, Inc.
New York, United States
Patent: 5
Guangdong Sheng, China
Patent: 5